Latest filing published 06 Oct 2026 for Eton Pharmaceuticals, Inc., €204k.
Insider track record
No signal scores available.
Krempa David: trading record in brief
Krempa David discloses dealings in Eton Pharmaceuticals, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 24 August 2026 to 6 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 6 October 2026, reports a transaction of €204k in Eton Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Krempa David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,166 shares@ US$55.0663CommonSEC144:0001974078-26-000377
- 25,000 shares@ US$65.070.088% mcap22.4% of flowCommonSEC144:0001974078-26-000328
2 of 2 declarations
